跳至主要内容
临床试验/CTRI/2024/07/070007
CTRI/2024/07/070007尚未招募2 期

Evaluation of the Safety & Efficacy of Ganga Water Phage Therapy (GWPT) plus Standard Medical Therapy (SMT) as compared to Standard Medical Therapy (SMT) alone for Helicobacter pylori-related Dyspepsia: A Randomized Control Trial. - None

Motilal Bhimraj Charity Trust0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Symptoms consistent with functional dyspepsia patients of at least two weeks’ duration (defined as recurrent pain or discomfort centered in the upper abdomen, often with a relation to meals).
  • 2. Positive for H. pylori by Rapid Urease Test.
  • 3. Male and female patients age ?18 years and ? 70 years.
  • 4. Agree to refrain from consuming alcohol from 1 week prior to screening.
  • 5. Agree to refrain from taking antacids from screening through day 15 and for at least 24 hours prior to test of detection and cure.
  • 6. Agree to refrain from taking H2 blockers at least 24 hours prior to screening RUT(Rapid Urease Test) and at least 24 hours prior to test of detection and cure.
  • 7. Agree to refrain from taking sucralfate, bismuth containing medications such as Pepto-Bismol TM or other proton pump inhibitors (PPIs) from two weeks prior to screening through test of detection and cure.
  • 8. Be able to give written informed consent.
  • 9. Be in generally good health as determined by the investigator
  • Have mild gastrointestinal discomfort, such as mild indigestion.
  • 10. No history of H. pylori eradication.

排除标准

  • 1. Symptoms/signs of unexplained anemia [iron deficiency], melena/hematemesis, anorexia, dysphagia, jaundice, weight loss).
  • 2. Have received prior H. pylori eradication therapy.
  • 3. Use of any proton pump inhibitors (PPIs) within the 2 weeks immediately prior to screening RUT (Rapid Urease Test).
  • 4. Presence of more than two active gastric and/or duodenal ulcers.
  • 5. History of gastric outlet obstruction; or hyper secretory state (e.g., Zollinger Ellison Syndrome);
  • 6. Have an active gastrointestinal disorder, concomitant end stage organ disease or History of previous gastrointestinal surgery, esophageal or gastric surgery, except for simple closure of perforated ulcer.
  • 7. History of gastric cancer
  • 8. Positive screening laboratory results for human immunodeficiency virus (HIV) antibody (HIV1 or HIV2), or hepatitis B surface antigen (HBs Ag), or hepatitis C antibody (HCV Ab).

研究者

发起方
Motilal Bhimraj Charity Trust

相似试验